Impact of metformin on the prognosis of unresectable hepatocellular carcinoma patients with type 2 diabetes mellitus receiving FOLFOX-based hepatic arterial infusion chemotherapy: A propensity score matching study
Impact of metformin on the prognosis of unresectable hepatocellular carcinoma patients with type 2 diabetes mellitus receiving FOLFOX-based hepatic arterial infusion chemotherapy: A propensity score matching study. // Liver Research. – URL: https://www.sciencedirect.com/science/article/pii/S2542568426000528?dgcid=rss_sd_all
Impact of metformin on the prognosis of unresectable hepatocellular carcinoma patients with type 2 diabetes mellitus receiving FOLFOX-based hepatic arterial infusion chemotherapy: A propensity score matching study. Liver Research. https://www.sciencedirect.com/science/article/pii/S2542568426000528?dgcid=rss_sd_all
“Impact of metformin on the prognosis of unresectable hepatocellular carcinoma patients with type 2 diabetes mellitus receiving FOLFOX-based hepatic arterial infusion chemotherapy: A propensity score matching study.” Liver Research.
@article{article57480,
title = {Impact of metformin on the prognosis of unresectable hepatocellular carcinoma patients with type 2 diabetes mellitus receiving FOLFOX-based hepatic arterial infusion chemotherapy: A propensity score matching study},
journal = {Liver Research},
url = {https://www.sciencedirect.com/science/article/pii/S2542568426000528?dgcid=rss_sd_all}
}